Nanomedicine News

RSS

Dopamine Packaged in Biodegradable Nanoparticles Reverses Parkinson's-Like Symptoms

As baby boomers age, the number of people diagnosed with Parkinson's disease is expected to increase. Patients who develop this disease usually start experiencing symptoms around age 60 or older. Currently, there's no cure, but scientists are reporting a novel approach that reversed Parkinson's-like symptoms in rats. Their results, published in the journal ACS Nano, could one day lead to a new therapy for human patients.

From American Chemical Society 23 Apr 2015

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Blend Therapeutics, Inc., a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, presented preclinical data today on its lead Pentarin™ program, BTP-277, showing specific and potent targeting of tumor cells expressing the somatostatin receptor, which is known to be over expressed in small cell lung cancer (SCLC) and neuroendocrine cancer tumor cells.

22 Apr 2015

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

Oasmia Pharmaceutical AB ("Oasmia") announced today that its lead cancer product Paclical received market authorization in the Russian Federation by the Russian Ministry of Health. Paclical is the first water-soluble cancer drug with paclitaxel to receive a market authorization. Paclical is planned for launch in the second half of 2015.

21 Apr 2015

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

NanoViricides, Inc., (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical symptoms associated with herpes simplex virus infection in the recently completed studies in mice. The studies were performed in the laboratory of Dr. Ken S. Rosenthal at Northeast Ohio Medical University where Dr. Rosenthal is now Professor Emeritus. He is a leading researcher in herpes virus anti-viral agents and vaccines.

From NanoViricides, Inc 21 Apr 2015

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Fastening protein-based medical treatments to nanoparticles isn't easy.

21 Apr 2015

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

For a healthy individual, an infection of Cryptosporidium parvum may mean nothing more than a few days of bad diarrhea. For someone with a compromised immune system, it can mean death, following an excruciating, protracted bout of watery diarrhea.

16 Apr 2015

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

InMed Pharmaceuticals Inc., a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabinoid-based therapies, today announced that it has been awarded a grant to further develop the Company's proprietary nanoparticle-based delivery system for their leading drug candidate CTI-085 for glaucoma.

16 Apr 2015

CEO of Cerulean Presents at Needham Healthcare Conference

Cerulean Pharma Inc., a leader in Dynamic Tumor Targeting™, today announced that Christopher D. T. Guiffre, President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on Wednesday, April 15th at 5:00 p.m. ET in New York.

16 Apr 2015

New Global Nanomedicine Market & Pipeline Insight 2015 Report

Research and Markets has announced the addition of the "Global Nanomedicine Market & Pipeline Insight 2015" report to their offering.

15 Apr 2015

Gold Nanoparticles Tethered to pHLIPs Increase Effectiveness of Cancer-Killing Radiation

Researchers from Brown University and the University of Rhode Island have demonstrated a promising new way to increase the effectiveness of radiation in killing cancer cells.

15 Apr 2015

Nanomedicine News

Dopamine Packaged in Biodegradable Nanoparticles Reverses Parkinson's-Like Symptoms

Blend Therapeutics Announces Presentation of Preclinical Data on Lead Pentarin Program, BTP-277

Oasmia's Paclical Nanoparticle Cancer Drug with Paclitaxel Receives Russian Health Ministry Market Authorization

Anti-Herpes Nanoviricides Reduce Extent of Disease and Mortality of HSV-1 Infected Animals

Easy, Effective Method to Fasten Proteins to Nanoparticles for Cancer Treatment

Lab-on-a-Chip Device for Rapid Diagnosis of Cryptosporidium Infections

InMed Receives Mitacs Grant to Further Develop Nanoparticle-Based Drug Delivery System for Glaucoma

CEO of Cerulean Presents at Needham Healthcare Conference

New Global Nanomedicine Market & Pipeline Insight 2015 Report

Gold Nanoparticles Tethered to pHLIPs Increase Effectiveness of Cancer-Killing Radiation

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting